相关实验视频
Updated: May 2, 2026
06:59
Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
37.1K
用Geniposide向自改善了小鼠[公式:参阅文本]中的动脉样硬化
Xiaodan Yang1, Jiaxi Shi2, Weifeng He2
1The Affiliated Traditional Chinese Medicine Hospital, Guangzhou Medical University, Guangdong, P. R. China.
The American journal of Chinese medicine
|December 17, 2024
概括
基尼胺 (GP) 通过增强自,有效治疗动脉样硬化 (AS). 这种天然化合物调节PI3K/Akt/mTOR通路,减少脂质积累和稳定斑块,有利于心血管健康.
科学领域:
- 心血管研究研究心血管研究
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
背景情况:
- 动脉样硬化 (AS) 是全球主要的死亡原因.
- 基尼化物 (GP),以脂解和抗炎作用而闻名,用于心血管疾病.
- 自在心血管健康中起着至关重要的作用,GP在AS中的机制需要阐明.
研究的目的:
- 调查基尼波 (GP) 在改善动脉样硬化 (AS) 的潜在机制.
- 为了确定GP是否通过PI3K/Akt/mTOR途径调节自,以治疗AS.
主要方法:
- 网络药理学和分子对接被用于初步机制预测.
- 使用了Oil Red O,Sirius Red,Mason的三色染色和免疫组织化学.
- 西部斑点 (WB) 和免疫光 (IF) 评估了与自和PI3K/Akt/mTOR通路相关的蛋白质水平.
主要成果:
- GP抑制了动脉样硬化脂质的积累,并稳定了斑块.
- 总理减少了巨细胞的透,通过减少F4/80表达来表明.
- 通过增加LC3和Beclin1,减少P62和抑制PI3K/Akt/mTOR酸化,GP促进了自.
结论:
- 基尼胺 (GP) 有效治疗动脉样硬化症 (AS).
- 通过PI3K/Akt/mTOR通路,GP可以增强自.
- 通过准AS机制,GP证明了心血管疾病的治疗潜力.
相关概念视频
01:27Autophagy
5.0K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.0K
01:29Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
01:26Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741